Pulmonary Cryptococcosis

Pulmonary cryptococcosis is the consequence of the inhalation of Cryptococcus neoformans, an encapsulated yeast, from various environmental sources. It is commonly accepted that the acquisition of the disease occurs early in life and that the disease is mostly related to a reactivation from a pulmonary site in immunocompromised hosts such as patients infected with human immunodeficiency virus. Clinical and radiological presentations of the disease are nonspecific and are more severe in immunocompromised hosts with acquired immunodeficiency syndrome (AIDS). However, fulminant forms have also been reported in apparently immunocompetent hosts. C. neoformans has rarely been responsible for colonization of the respiratory tract; this usually occurs in immunocompetent hosts with preexisting pulmonary disease. Diagnosis of pneumonia is obtained by either analysis of bronchoalveolar lavage in AIDS patients or by the histology/mycological analysis of a pulmonary nodule. In any case, a careful work-up for diagnosing dissemination should always be performed. Antifungal treatment has to be given in most of the immunocompetent hosts and always in those with any kind of immunodeficiency with isolated pulmonary cryptococcosis.

Cryptococcus neoformans - pneumonia - AIDS - fluconazole

REFERENCES

• 1 Kwon-Chung K J, Bennett J E. Cryptococcosis. In: Kwon-Chung KJ, Bennett JE Medical Mycology. Philadelphia; Lea & Febiger 1992: 397-446
• 2 Neuville S, Dromer F, Morin O et al.. Primary cutaneous cryptococcosis, a distinct clinical entity.  Clin Infect Dis. 2003;  36 337-347
• 3 Baker R D. The primary lymph node complex of cryptococcosis.  Am J Clin Pathol. 1976;  65 83-92
• 4 Dromer F, Mathoulin S, Dupont B, Laporte A. and the French Cryptococcosis Study Group . Epidemiology of cryptococcosis in France: 9-year survey (1985-1993).  Clin Infect Dis. 1996;  23 82-90
• 5 Mirza S A, Phelan M, Rimland D et al.. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.  Clin Infect Dis  2003;  36 789-794
• 6 Chen K Y, Ko S C, Hsueh P R, Luh K T, Yang P C. Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors.  Chest. 2001;  120 177-184
• 7 Krumholz R A. Pulmonary cryptococcosis: a case due to Cryptococcus albidus .  Am Rev Respir Dis. 1972;  105 421-424
• 8 Lynch III J P, Schaberg D R, Kissner D G, Kauffman C A. Cryptococcus laurentii lung abcess.  Am Rev Respir Dis. 1981;  123 135-138
• 9 Casadevall A, Perfect J R. Cryptococcus neoformans. Washington, DC; American Society for Microbiology 1998
• 10 Buchanan K L, Murphy J W. What makes Cryptococcus neoformans a pathogen?.  Emerg Infect Dis. 1998;  4 71-83
• 11 Chen S CA, Muller M, Zhou J Z, Wright L C, Sorrell T C. Phospholipase activity in Cryptococcus neoformans: a new virulence factor?.  J Infect Dis. 1997;  175 414-420
• 12 Kozel T R, Levitz S M, Dromer F, Gates M A, Thorkildson P, Janbon G. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.  Infect Immun. 2003;  71 2868-2875
• 13 Kwon-Chung K J, Bennett J E. Epidemiologic differences between the two varieties of Cryptococcus neoformans .  Am J Epidemiol. 1984;  120 123-130
• 14 Bennett J E, Kwon-Chung K J, Theodore T S. Biochemical differences between serotypes of Cryptococcus neoformans .  Sabouraudia. 1978;  16 167-174
• 15 Franzot S P, Salkin I F, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.  J Clin Microbiol. 1999;  37 838-840
• 16 Sorell T C. Cryptococcus neoformans variety gattii .  Med Mycol. 2001;  39 155-168
• 17 Dromer F, Mathoulin S, Dupont B, Letenneur L, Ronin O. and the French Cryptococcosis Study Group . Individual and environmental factors associated with Cryptococcus neoformans serotype D infections in France.  Clin Infect Dis. 1996;  23 91-96
• 18 Chen S, Sorrell T, Nimmo G et al.. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand.  Clin Infect Dis. 2000;  31 499-508
• 19 Mitchell D H, Sorrell T C, Allworth A M et al.. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.  Clin Infect Dis. 1995;  20 611-616
• 20 Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans .  Clin Infect Dis. 1995;  21 28-34
• 21 Fyfe M, Black W, Romney M et al.. Unprecedented outbreak of Cryptococcus neoformans var. gattii infections in British Columbia, Canada. Paper presented at: 5th International Conference on Cryptococcus and Cryptococcosis 2002 Adelaide, Australia;
• 22 Currie B P, Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.  Clin Infect Dis. 1994;  19 1029-1033
• 23 Mitchell T G, Perfect J R. Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans .  Clin Microbiol Rev. 1995;  8 515-548
• 24 Dromer F, Mathoulin S, Dupont B, Brugière O, Letenneur L. the French Cryptococcosis Study Group . Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases.  Clin Infect Dis. 1996;  22(suppl 2) S154-S160
• 25 Chen S. and the Australasian Society for Infectious Diseases (ASID) Mycoses Interest Group . Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B.  J Antimicrob Chemother. 2002;  49(suppl S1) 57-61
• 26 van Elden L JR, Walenkamp A ME, Lipovsky M M et al.. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy.  AIDS. 2000;  14 2787-2800
• 27 Dromer F, Mathoulin-Pélissier S, Fontanet A, Ronin O, Dupont B, Lortholary O. on behalf of the French Cryptococcosis Study Group . Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras.  AIDS. 2004;  18 555-562
• 28 Tansuphasawadikul S, Amornkul P N, Tanchanpong C et al.. Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand.  J Acquir Immune Defic Syndr. 1999;  21 326-332
• 29 Imwidthaya P, Sthakorn C, Prucksunand C, Prajakthram R, Sukroongrung S. Cryptococcal meningitis in AIDS at Siriraj hospital.  J Infect Dis Antimicrob Agents. 1997;  14 87-91
• 30 Hakim J G, Gangaidzo I T, Heyderman R S et al.. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients.  AIDS. 2000;  14 1401-1407
• 31 Corbett E L, Churchyard G J, Charalambos S et al.. Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus.  Clin Infect Dis. 2002;  34 1251-1258
• 32 Hajjeh R A, Conn L A, Stephens D S et al.. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group.  J Infect Dis. 1999;  179 449-454
• 33 Diamond R D, Bennett J E. Prognostic factors in cryptococcal meningitis: a study in 111 cases.  Ann Intern Med. 1974;  80 176-181
• 34 Pappas P G, Perfect J R, Cloud G A et al.. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.  Clin Infect Dis. 2001;  33 690-699
• 35 Husain S, Wagener M M, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variable influencing clinical characteristics and outcome.  Emerg Infect Dis. 2001;  7 375-381
• 36 Singh N. Clinical and environmental factors associated with cryptococcosis in liver transplant recipients.  Clin Infect Dis. 1997;  24 744-745
• 37 Vilchez R A, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: an overview.  Am J Transplant. 2002;  2 575-580
• 38 Bennett J E, Dismukes W E, Duma R J et al.. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis.  N Engl J Med. 1979;  301 126-131
• 39 Duncan R A, von Reyn C F, Alliegro G M, Toossi Z, Sugar A M, Levitz S M. Idiopathic CD4+ T-lymphocytopenia: four patients with opportunistic infections and no evidence of HIV infection.  N Engl J Med. 1993;  328 393-398
• 40 Ely E W, Peacock Jr J E, Haponik E F, Washburn R G. Cryptococcal pneumonia complicating pregnancy.  Medicine (Baltimore). 1998;  77 153-167
• 41 Leggiadro R J, Barrett F F, Hughes W T. Extrapulmonary cryptococcosis in immunocompromised infants and children.  Pediatr Infect Dis J. 1992;  11 43-47
• 42 Leggiadro R J, Kline M W, Hughes W T. Extrapulmonary cryptococcosis in children with acquired immunodeficiency syndrome.  Pediatr Infect Dis J. 1991;  10 658-662
• 43 Abadi J, Nachman S, Kressel A B, Pirofski L-A. Cryptococcosis in children with AIDS.  Clin Infect Dis. 1999;  28 309-313
• 44 Rozenbaum R, Rios Gonçalves A J. Clinical epidemiology study of 171 cases of cryptococcosis.  Clin Infect Dis. 1994;  18 369-380
• 45 Goldman D L, Khine H, Abadi J et al.. Serologic evidence for Cryptococcus neoformans infection in early childhood.  Pediatrics. 2001;  107 E66
• 46 Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection.  J Clin Microbiol. 1999;  37 3204-3209
• 47 Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans .  Med Mycol. 2000;  38 407-417
• 48 Vilchez R A, Linden P, Lacomis J, Costello P, Fung J, Kusne S. Acute respiratory failure associated with pulmonary cryptococcosis in non-aids patients .  Chest. 2001;  119 1865-1869
• 49 Campbell G D. Primary pulmonary cryptococcosis.  Am Rev Respir Dis. 1966;  94 236-243
• 50 Hammerman K J, Powell K E, Christianson C S et al.. Pulmonary cryptococcosis: clinical form and treatment.  Am Rev Resp Dis. 1973;  108 1116-1123
• 51 Wu T T, Wang H C, Yang P C, Kuo S H, Luh K T. Pulmonary cryptococcosis: manifestations in the era of acquired immunodeficiency syndrome.  J Formos Med Assoc. 1999;  98 621-626
• 52 Young E J, Hirsh D D, Fainstein V, Williams T W. Pleural effusions due to Cryptococcus neoformans: a review of the literature and report of two cases with cryptococcal antigen determinations.  Am Rev Respir Dis. 1980;  121 743-747
• 53 Vilchez R A, Irish W, Lacomis J, Costello P, Fung J, Kusne S. The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center.  Medicine (Baltimore). 2001;  80 308-312
• 54 Aberg J A, Mundy L M, Powderly W G. Pulmonary cryptococcosis in patients without HIV infection.  Chest. 1999;  115 734-740
• 55 Kerkering T M, Duma R J, Shadomy S. The evolution of pulmonary cryptococcosis: clinical implication from a study of 41 patients with and without compromising factors.  Ann Intern Med. 1981;  94 611-616
• 56 Nunez M, Peacock J EJ, Chin R J. Pulmonary cryptococcosis in the immunocompetent host.  Chest. 2000;  118 527-534
• 57 LaGatta M A, Jordan C, Khan W, Toomey J. Isolated pulmonary cryptococcosis in pregnancy.  Obstet Gynecol. 1998;  92(4 pt 2) 682-684
• 58 Balloul E, Couderc L J, Molina J M et al.. Pulmonary cryptococcosis during HIV infection. 15 cases [in French].  Rev Mal Respir. 1997;  14 365-370
• 59 Cameron M L, Bartlett J A, Gallis H A, Waskin H A. Manifestations of pulmonary cryptococcosis in patients with the acquired immunodeficiency syndrome.  Rev Infect Dis. 1991;  13 64-67
• 60 Chechani V, Kamholz S L. Pulmonary manifestations of disseminated cryptococcosis in patients with AIDS.  Chest. 1990;  98 1060-1066
• 61 Clark R A, Greer D L, Valainis G T, Hyslop N E. Cryptococcus neoformans pulmonary infection in HIV-1-infected patients.  J Acquir Immune Defic Syndr. 1990;  3 480-484
• 62 Meyohas M C, Roux P, Bollens D et al.. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS.  Clin Infect Dis. 1995;  21 628-633
• 63 Driver J A, Saunders C A, Heinze-Lacey B, Sugar A M. Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia?.  J Acquir Immune Defic Syndr Hum Retrovirol. 1995;  9 168-171
• 64 Batungwanayo J, Taelman H, Bogaerts J et al.. Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda: a retrospective study of 37 cases.  AIDS. 1994;  8 1271-1276
• 65 Newman T G, Soni A, Acaron S, Huang C T. Pleural cryptococcosis in the acquired immunodeficiency syndrome.  Chest. 1987;  91 459-461
• 66 Torre D, Martegani R, Speranza F, Zeroli C, Fiori G P. Pulmonary cryptococcosis presenting as pneumothorax in a patient with AIDS.  Clin Infect Dis. 1995;  21 1524-1525
• 67 Visnegarwala F, Graviss E A, Lacke C E et al.. Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factors.  Clin Infect Dis. 1998;  27 1231-1237
• 68 Bernicker E H, Atmar R L, Schaffner D L, Greenberg S B. Unanticipated diagnoses found at autopsy in an urban public teaching hospital.  Am J Med Sci. 1996;  311 215-220
• 69 Lanjewar D N, Duggal R. Pulmonary pathology in patients with AIDS: an autopsy study from Mumbai.  HIV Med. 2001;  2 266-271
• 70 Miller K D, Mican J A, Davey R T. Asymptomatic solitary pulmonary nodules due to Cryptococcus neoformans in patients infected with human immunodeficiency virus.  Clin Infect Dis. 1996;  23 810-812
• 71 Memain N, Blanche P, Benveniste O et al.. Paradoxical reactions due to immune restoration during Cryptococcus neoformans infection in AIDS. Paper presented at: 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2001 Chicago, IL;
• 72 Jenny-Avital E R, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy.  Clin Infect Dis. 2002;  35 128-133
• 73 Shelburne III S A, Hamill R J, Rodriguez-Barradas M C et al.. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.  Medicine. 2002;  81 213-227
• 74 Emmons III W W, Luchsinger S, Miller L. Progressive pulmonary cryptococcosis in a patient who is immunocompetent.  South Med J. 1995;  88 657-660
• 75 Mahida P, Morar R, Goolam Mahomed A, Song E, Tissandie J P, Feldman C. Cryptococcosis: an unusual cause of endobronchial obstruction.  Eur Respir J. 1996;  9 837-839
• 76 Ziomek S, Weinstein W, Margulies M, Braun R A. Primary pulmonary cryptococcosis presenting as a superior sulcus tumor.  Ann Thorac Surg. 1992;  53 892-893
• 77 Mitchell D H, Sorrell T C. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii .  Clin Infect Dis. 1992;  14 1142-1144
• 78 Lehmann P F, Morgan R J, Freimer E H. Infection with Cryptococcus neoformans var. gattii leading to a pulmonary cryptococcoma and meningitis.  J Infect. 1984;  9 301-306
• 79 Khoury M B, Godwin J D, Ravin C E, Gallis H A, Halvorsen R A, Putman C E. Thoracic cryptococcosis: immunologic competence and radiologic appearance.  AJR Am J Roentgenol. 1984;  142 893-896
• 80 Feigin D S. Pulmonary cryptococcosis: radiologic-pathologic correlates of its three forms.  AJR Am J Roentgenol. 1983;  141 1262-1272
• 81 Patz Jr E F, Goodman P C. Pulmonary cryptococcosis.  J Thorac Imaging. 1992;  7 51-55
• 82 Roebuck D J, Fisher D A, Currie B J. Cryptococcosis in HIV negative patients: findings on chest radiography.  Thorax. 1998;  53 554-557
• 83 Boyars M C, Zwischenberger J B, Cox Jr C S. Clinical manifestations of pulmonary fungal infections.  J Thorac Imaging. 1992;  7 12-22
• 84 Woodring J H, Ciporkin G, Lee C, Worm B, Woolley S. Pulmonary cryptococcosis.  Semin Roentgenol. 1996;  31 67-75
• 85 Miller Jr W T, Edelman J M, Miller W T. Cryptococcal pulmonary infection in patients with AIDS: radiographic appearance.  Radiology. 1990;  175 725-728
• 86 Stansell J D. Pulmonary fungal infections in HIV-infected persons.  Semin Respir Infect. 1993;  8 116-123
• 87 Sider L, Westcott M A. Pulmonary manifestations of cryptococcosis in patients with AIDS: CT features.  J Thorac Imaging. 1994;  9 78-84
• 88 Lacomis J M, Costello P, Vilchez R, Kusne S. The radiology of pulmonary cryptococcosis in a tertiary medical center.  J Thorac Imaging. 2001;  16 139-148
• 89 Haramati L B, Jenny-Avital E R. Approach to the diagnosis of pulmonary disease in patients infected with the human immunodeficiency virus.  J Thorac Imaging. 1998;  13 247-260
• 90 Zinck S E, Leung A N, Frost M, Berry G J, Muller N L. Pulmonary cryptococcosis: CT and pathologic findings.  J Comput Assist Tomogr. 2002;  26 330-334
• 91 Lee L N, Yang P C, Kuo S H, Luh K T, Chang D B, Yu C J. Diagnosis of pulmonary cryptococcosis by ultrasound guided percutaneous aspiration.  Thorax. 1993;  48 75-78
• 92 Liaw Y S, Yang P C, Yu C J et al.. Direct determination of cryptococcal antigen in transthoracic needle aspirate for diagnosis of pulmonary cryptococcosis.  J Clin Microbiol. 1995;  33 1588-1591
• 93 Trevenzoli M, Cattelan A M, Rea F et al.. Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era.  J Infect. 2002;  45 173-179
• 94 Maesaki S, Kohno S, Mashimoto H, Araki J, Asai S, Hara K. Detection of Cryptococcus neoformans in bronchial lavage cytology: report of four cases.  Intern Med. 1995;  34 54-57
• 95 Sandhu G S, Kline B C, Stockman L, Roberts G D. Molecular probes for diagnosis of fungal infections.  J Clin Microbiol. 1995;  33 2913-2919
• 96 Luo G, Mitchell T G. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR.  J Clin Microbiol. 2002;  40 2860-2865
• 97 Chang H C, Leaw S N, Huang A H, Wu T L, Chang T C. Rapid identification of yeasts in positive blood cultures by a multiplex PCR method.  J Clin Microbiol. 2001;  39 3466-3471
• 98 Hendolin P H, Paulin L, Koukila-Kahkola P et al.. Panfungal PCR and multiplex liquid hybridization for detection of fungi in tissue specimens.  J Clin Microbiol. 2000;  38 4186-4192
• 99 Randhawa H S, Paliwal D K. Occurrence and significance of Cryptococcus neoformans in the oropharynx and on the skin of a healthy population.  J Clin Microbiol. 1977;  6 325-327
• 100 Duperval R, Hermans P E, Brewer N S, Roberts G D. Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract.  Chest. 1977;  72 13-19
• 101 Kakeya H, Udono H, Maesaki S et al.. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.  Clin Exp Immunol. 1999;  115 485-490
• 102 Bloomfield N, Gordon M A, Elmendorf D FJ. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination.  Proc Soc Exp Biol Med. 1963;  114 64-67
• 103 Temstet A, Roux P, Poirot J L, Ronin O, Dromer F. Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies.  J Clin Microbiol. 1992;  30 2544-2550
• 104 Currie B P, Freundlich L F, Soto M A, Casadevall A. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis.  J Clin Microbiol. 1993;  31 2519-2522
• 105 Chuck S L, Sande M A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.  N Engl J Med. 1989;  321 794-799
• 106 Hamilton J R, Noble A, Denning D W, Stevens D A. Performance of Cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment.  J Clin Microbiol. 1991;  29 333-339
• 107 Baughman R P, Rhodes J C, Dohn M N, Henderson H, Frame P T. Detection of cryptococcal antigen in bronchoalveolar lavage fluid: a prospective study of diagnostic utility.  Am Rev Resp Dis. 1992;  145 1226-1229
• 108 Bottone E J, Sindone M, Caraballo V. Value of assessing cryptococcal antigen in bronchoalveolar lavage and sputum specimens from patients with AIDS.  Mt Sinai J Med. 1998;  65 422-425
• 109 White M, Cirrincione C, Blevins A, Armstrong D. Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease.  J Infect Dis. 1992;  165 960-963
• 110 Vilchez R, Shapiro R, McCurry K et al.. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients.  Transpl Int. 2003;  16 336-340
• 111 Taelman H, Bogaerts J, Batungwanayo J, Van de Perre P, Lucas S, Allen S. Failure of the cryptococcal serum antigen test to detect primary pulmonary cryptococcosis in patients infected with human immunodeficiency virus.  Clin Infect Dis. 1994;  18 119-120
• 112 Powderly W G, Cloud G A, Dismukes W E, Saag M S. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.  Clin Infect Dis. 1994;  18 789-792
• 113 Dannaoui E, Abdul M, Arpin M et al.. Lack of correlation between antifungal in vitro susceptibility of Cryptococcus neoformans and early outcome. Paper presented at: 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy 2003 Chicago, IL;
• 114 Witt M D, Lewis R J, Larsen R A et al.. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.  Clin Infect Dis. 1996;  22 322-328
• 115 Aller A I, Martin-Mazuelos E, Lozano F et al.. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.  Antimicrob Agents Chemother. 2000;  44 1544-1548
• 116 Armengou A, Porcar C, Mascaro J, Garcia-Bragado F. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis.  Clin Infect Dis. 1996;  23 1337-1338
• 117 Powderly W G, Keath E JS-AM, Robinson K, Kitz D, Little J R, Kobayashi G. Amphotericin B-resistant Cryptococcus neoformans in a patient with AIDS.  Infect Dis Clin Prac. 1992;  1 314-316
• 118 Rodero L, Cordoba S, Cahn P et al.. In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.  J Antimicrob Chemother. 2000;  45 239-242
• 119 Barchiesi F, Schimizzi A M, Caselli F et al.. Interactions between triazoles and amphotericin B against Cryptococcus neoformans .  Antimicrob Agents Chemother. 2000;  44 2435-2441
• 120 Schwarz P, Dromer F, Lortholary O, Dannaoui E. In vitro interaction of flucytosine in combination with conventional and new antifungals against clinical isolates of Cryptococcus neoformans .  Antimicrob Agents Chemother. 2003;  47 3361-3364
• 121 Dromer F, Varma A, Ronin O, Mathoulin S, Dupont B. Molecular typing of Cryptococcus neoformans serotype D clinical isolates.  J Clin Microbiol. 1994;  32 2364-2371
• 122 Ikeda R, Shinoda T, Fukazawa Y, Kaufman L. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.  J Clin Microbiol. 1982;  16 22-29
• 123 Dromer F, Guého E, Ronin O, Dupont B. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.  J Clin Microbiol. 1993;  31 359-363
• 124 Gal A A, Koss M N, Hawkins J, Evans S, Einstein H. The pathology of pulmonary cryptococcal infections in the acquired immunodeficiency syndrome.  Arch Pathol Lab Med. 1986;  110 502-507
• 125 Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.  Infect Immun. 2000;  68 4225-4237
• 126 Torda A, Kumar R K, Jones P D. The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii .  Pathology. 2001;  33 475-478
• 127 Utz J P, Tynes B S, Shadomy H J, Duma R J, Kannan M M, Mason K N. 5-Fluorocytosine in human cryptococcosis.  Antimicrob Agents Chemother. 1968;  8 344-346
• 128 Saag M S, Graybill R J, Larsen R A et al.. Practice guidelines for the management of cryptococcal disease.  Clin Infect Dis. 2000;  30 710-718
• 129 Robinson P A, Bauer M, Leal M AE et al.. Early mycological treatment failure in AIDS-associated cryptococcal meningitis.  Clin Infect Dis. 1999;  28 82-92
• 130 Powderly W G, Saag M S, Cloud G A et al.. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.  N Engl J Med. 1992;  326 793-798
• 131 Saag M S, Cloud G A, Graybill J R et al.. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.  Clin Infect Dis. 1999;  28 291-296
• 132 Nwokolo N C, Fisher M, Gazzard B G, Nelson M R. Cessation of secondary prophylaxis in patients with cryptococcosis.  AIDS. 2001;  15 1438-1439
• 133 Aberg J A, Price R W, Heeren D M, Bredt B. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy.  J Infect Dis. 2002;  185 1179-1182
• 134 Lortholary O, Droz C, Sitbon K et al.. Long-term outcome of HIV-associated cryptococcosis (CC) at the time of HAART: results of the Multicenter Cohort “Cryptostop”. Paper presented at: 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy 2003 Chicago, IL;
• 135 Smith F S, Gibson P, Nicholls T T, Simpson J A. Pulmonary resection for localized lesions of cryptococcosis (torulosis): a review of eight cases.  Thorax. 1976;  31 121-126